Sophia Apostolidou

ORCID: 0000-0003-2659-0451 · 4 papers in corpus
diagnostic-accuracy 2024
Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle-Based Blood Test: Performance in a Training and Verification Cohort
The Journal of molecular diagnostics : JMD ·doi:10.1016/j.jmoldx.2024.09.001

The low incidence of ovarian cancer (OC) dictates that any screening strategy needs to be both highly sensitive and highly specific. This study explored the utility of detecting multiple colocalized proteins or glycosylation epitopes on sin…

rct 2022
Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS
BJOG : an international journal of obstetrics and gynaecology ·doi:10.1111/1471-0528.16943

OBJECTIVE: To investigate the association between hysterectomy with conservation of one or both adnexa and ovarian and tubal cancer. DESIGN: Prospective cohort study. SETTING: Thirteen NHS Trusts in England, Wales and Northern Ireland. P…

other 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
Journal of Clinical Oncology ·doi:10.1200/jco.2014.59.4945

PURPOSE: Cancer screening strategies have commonly adopted single-biomarker thresholds to identify abnormality. We investigated the impact of serial biomarker change interpreted through a risk algorithm on cancer detection rates. PATIENTS …

rct 2014
Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
BMJ open ·doi:10.1136/bmjopen-2013-004421

OBJECTIVE: To evaluate the validity of self-reported hysterectomy against the gold standard of uterine visualisation using pelvic ultrasound. DESIGN: Prospective cohort study. SETTING: UK Collaborative Trial of Ovarian Cancer Screening (U…